Pityriasis rosea developing after COVID-19 vaccination

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Marcantonio-Santa Cruz, Orianna Yilsy
  • dc.contributor.author Vidal-Navarro, Ainhoa
  • dc.contributor.author Pesqué, David
  • dc.contributor.author Giménez Arnau, Anna Maria
  • dc.contributor.author Pujol Vallverdú, Ramon Maria
  • dc.contributor.author Martin-Ezquerra, Gemma
  • dc.date.accessioned 2022-03-29T06:41:53Z
  • dc.date.issued 2021
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Marcantonio-Santa Cruz OY, Vidal-Navarro A, Pesqué D, Giménez-Arnau AM, Pujol RM, Martin-Ezquerra G. Pityriasis rosea developing after COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e721-e722. DOI: 10.1111/jdv.17498
  • dc.identifier.doi http://dx.doi.org/10.1111/jdv.17498
  • dc.identifier.issn 0926-9959
  • dc.identifier.uri http://hdl.handle.net/10230/52788
  • dc.language.iso eng
  • dc.publisher Wiley
  • dc.relation.ispartof J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e721-e722
  • dc.rights This is the peer reviewed version of the following article: Marcantonio-Santa Cruz OY, Vidal-Navarro A, Pesqué D, Giménez-Arnau AM, Pujol RM, Martin-Ezquerra G. Pityriasis rosea developing after COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e721-e722. DOI: 10.1111/jdv.17498, which has been published in final form at http://dx.doi.org/10.1111/jdv.17498. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.title Pityriasis rosea developing after COVID-19 vaccination
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/acceptedVersion